SCHEMBL11815605

SCHEMBL11815605

CCCCN(CCCC)S(=O)(=O)c1cc(SCc2ccccc2)cc(C(=O)O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 4/20 0.46
▸ CA9 Q16790 4/20 0.46
▸ CA2 P00918 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ SLC22A6 Q4U2R8 1/20 0.46
▸ SLC22A8 Q8TCC7 1/20 0.46
▸ ABCC2 Q92887 1/20 0.46
▸ SLC22A12 Q96S37 1/20 0.46
▸ UGT1A7 Q9HAW7 1/20 0.46
▸ SLC22A11 Q9NSA0 1/20 0.46
▸ TAS2R14 Q9NYV8 5/20 0.46
▸ ALOX5 P09917 1/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.42
▸ TP53 P04637 1/20 0.41
▸ MCL1 Q07820 1/20 0.40
▸ BCL2A1 Q16548 1/20 0.40
▸ POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11822899 0.91 SMN1; SMN2 (0.44) CA12CA9CA2RAB9ASMN1; SMN2
SCHEMBL11816193 0.90 KMT2A (0.44) CA12CA9CA2RAB9ASMN1; SMN2
SCHEMBL11815261 0.87 CNR2 (0.46) CA12CA9CA2RAB9ASMN1; SMN2
SCHEMBL11816911 0.86 CA12 (0.47) CA12CA9CA2RAB9ASMN1; SMN2
SCHEMBL11819494 0.86 CNR2 (0.47) CA12CA9CA2RAB9ASMN1; SMN2
SCHEMBL11816930 0.86 TAS2R14 (0.59) TAS2R14MEN1KMT2APTGES
SCHEMBL11827713 0.86 KMT2A (0.43) CA12CA9CA2RAB9ASMN1; SMN2
SCHEMBL11822961 0.84 ALDH1A1 (0.49) RAB9ASMN1; SMN2TAS2R14MEN1KMT2A
SCHEMBL11819988 0.81 LMNA (0.46) TAS2R14ALOX5MEN1KMT2AMCL1
SCHEMBL11820805 0.77 CA2 (0.48) CA12CA9CA2RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3954994-A Intermediates for preparing hipolipemic agents and method of lowering the blood lipid level in mammals with said agents PFIZER INC. (US) 1976-05-04 — — US disclosed
Send feedback